A breakthrough for food allergies.
A study published Sunday in the New England Journal of Medicine reveals that Xolair, a drug already known and used for the treatment of asthma, is effective in preventing allergic reactions linked to several foods.
The American Medicines Agency (FDA) authorized this treatment on February 16 for this specific use and for adults and children over one year old.
The patients involved in the study who benefited from the treatment, 177 children aged 1 to 17 years old and all allergic, were able to see a significant growth in their tolerance to food products such as peanuts, nuts, eggs, milk and wheat.
Also read Food allergies: “People always think we’re exaggerating”
These results show that such treatment “can significantly reduce the occurrence of allergic reactions to several foods in the event of accidental exposure,” said Robert Wood, the lead author of the study, in a press release released by Rock.
The Swiss pharmaceutical giant owns the Californian laboratory Genentech, to which the FDA has given authorization, and co-distributes Xolair with Novartis in the United States.
Regular injections for several weeks
Omalizumab, the scientific name for Xolair, is a monoclonal antibody that blocks the action of antibodies that cause allergic reactions.
At the end of a period of regular injections over 16 to 20 weeks, 67% of patients who actually received omalizumab, for example, tolerated a dose of 600 mg of peanuts, compared to only 7% of patients who received the placebo. , reveals this study, funded by the US Department of Health.
If these results are encouraging, they should not suggest that beneficiaries could resume consuming allergens, insists the FDA, the aim being only to reduce the reaction in the event of accidental ingestion.
Xolair is considered safe, with the main associated side effects being fever and an injection site reaction, she notes.
Authorized in 2003 for asthma, Xolair has since also been authorized for the treatment of chronic spontaneous urticaria.
Also read: Eating broccoli or cabbage can limit skin allergies, according to a study
This discovery comes at a time when food allergies are of growing concern in the country.
They affect some 2% of adults and “between 4 and 8%” of children in the United States, we can read on the website of the Centers for Disease Prevention and Control (CDC).
These food allergies are the cause of some 30,000 emergency room visits and 150 deaths each year in the country, according to the authorities.